Tagged with USA

Pharma Eduardo Negrón-Navas, attorney-at-law, for the Puerto Rican law firm Fiddler, González & Rodríguez, discusses the firm’s long-standing service to the pharmaceutical industry and the need for both government and industry to reinvent a business model better defined for the new realities of the 21st century. What is your evaluation of…

Pharma M&N Electronic Inc., also referred to as G.O.D Enterprises, provides hi-tech doors and material handling to the life sciences manufacturing industries of Puerto Rico and the Dominican Republic. The company’s president, Manuel De La Cruz, outlines M&N’s rapid growth since its inception in 2008 and future expansion opportunities. How did…

Pharma Andrés Soto and Luis Baez co-founded ISPV (Integrated Services for Productivity and Validation) in 2007. As a relative latecomer to the validation market of Puerto Rico, they explain how they capitalized upon their previous experience to become one of the fastest-growing service providers in the Puerto Rican pharmaceutical and food…

Francisco Arteaga-Martínez Francisco Arteaga-Martínez founded Caribbean Project Management (CPM) in 1991. Since then, the company has expanded considerably, with a presence now in Florida and Panama as a leading Puerto Rican construction management provider. He discusses the history, growth and key assets of the company. What were your intentions behind starting CPM?…

Pharma José M. Jiménez, Vice President and General Manager of Torcon Puerto Rico, outlines current construction projects within the life science and healthcare industries on the island while highlighting the branch office’s strong expertise. Jimenez is one of the nation’s top 40 construction managers according to Engineering News Record (ENR). Given the dynamic…

Pharma José Luis Rodríguez, CEO of Hospital Pavia Santurce, explains how budget cuts to Puerto Rico’s healthcare system will have a dramatic impact on the country’s hospitals, and outlines how medical tourism can be promoted more to bring more patients to the island. What is your current assessment of Puerto Rico’s…

Pharma Juan Sénquiz, President and CEO of JC Automation, weighs in on the capacity of Puerto Rico’s local pharma service industry to grow globally and how the company’s computerized systems services have helped some of the biggest names in the industry to automate more effectively. We have seen a lot of…

Pharma Founded in 2010, N&CS Consulting Group has quickly become one of Puerto Rico’s leading providers for computer systems validation and engineering to the life science industry. Its founder and president, Néstor Cardona, traces the evolution of N&CS over the last five years provides his outlook on the current state of…

Pharma With over forty years of operations in Puerto Rico, Medtronic is one of the country’s biggest employers. Felix M. Negrón, Vice President of Medtronic Puerto Rico Operations, discusses the affiliate’s operating imperatives and space utilization strategy to always ensure the best manufacturing portfolio at any given time. Could you start…

Pharma Michel van Agthoven outlines the role played by the Pharmaceutical Committee of the American Chamber in contributing to healthcare related policies in the Netherlands through research programs and by encouraging collaboration between stakeholders. The Committee aims to contribute to the improvement of key aspects of the healthcare system in the…

Pharma Over the past few years BMS has consolidated its footprint in Puerto Rico to transform the island into a manufacturing hub for both biopharma and pharmaceuticals. The plant manager of the oral solid Humacao plant discusses the current challenges the site is facing as well as the company’s future development…

Pharma Bristol-Myers Squibb (BMS) has made major restructuring changes to its manufacturing processes. Ricardo Zayas, senior vice president of global pharmaceutical manufacturing for BMS, outlines these changes while underscoring the importance of development teams working in tandem with production to become more efficient in launching new innovation. What do you see as…